Drug Information

Drug General Information
Drug ID
D04GAX
Former ID
DNC014112
Drug Name
3-(4,5-Dihydrooxazol-2-yl)phenyl propylcarbamate
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530218]
Formula
C13H16N2O3
Canonical SMILES
CCCNC(=O)OC1=CC=CC(=C1)C2=NCCO2
InChI
1S/C13H16N2O3/c1-2-6-15-13(16)18-11-5-3-4-10(9-11)12-14-7-8-17-12/h3-5,9H,2,6-8H2,1H3,(H,15,16)
InChIKey
JLCYRBIRENXOKD-UHFFFAOYSA-N
PubChem Compound ID
44243876
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [530218]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 530218Eur J Med Chem. 2009 Oct;44(10):4179-91. Epub 2009 May 22.Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields.
Ref 530218Eur J Med Chem. 2009 Oct;44(10):4179-91. Epub 2009 May 22.Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields.